Stock DBD DIEBOLD NIXDORF, INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Diebold Nixdorf, Incorporated Nyse

Equities

DBD

US2536511031

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wedbush Raises Diebold Nixdorf's PT to $40 From $25 After Debt Repayment, 'Strong' Q4 2023 Execution; Keeps Neutral Rating
MT
DA Davidson Upgrades Diebold Nixdorf to Buy From Neutral, Raises Price Target to $29 From $25
MT
Wedbush Raises Diebold Nixdorf's PT to $25 From $20 in Light of Higher Earnings Expectations Moving Forward, Keeps Neutral Rating
MT
Wedbush Raises Diebold Nixdorf's PT to $20 From $1 After Exiting Bankruptcy, Notes Improved Capital Structure; Keeps Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DBD Stock
  4. DBD Stock
  5. News Diebold Nixdorf, Incorporated
  6. Analyst Reco.